Hawkinvest
Contributor since: 2011
Latest Articles
Join Perceptive Advisors And Buy VBI Vaccines At $2 Now
Aehr Test Systems: With Major Revenue Growth, This $2 Chip Stock Is A Strong Buy
Blue Capital Reinsurance: A Strong Buy For Rebound Potential And A 10%+ Yield
Bargain Hunting: 4 Reasons To Buy Libbey At $6 Per Share
The Market Has Bottomed Out: Here's What To Buy Now
Tofutti Brands: This Undervalued Food Stock Appears Poised For A Buyout In 2018
Teligent: This $3 Growth Stock Is Undervalued And Poised For A January Short Squeeze
My 3 Top Dividend Stock Picks For 2018
Libbey: Beaten Down Like A Coiled Spring, This $6 Dividend Stock Is A Top Rebound Pick For 2018
Aehr Test Systems: Buy This $2 Chip Stock For 2018 Growth Potential
Scynexis: This Cash-Rich $2 Biotech Stock Is A Strong Buy Before 2018
Ceragon Networks: This Undervalued $2 Tech Stock Can Win Big As 5G Rolls Out
Willbros: A Selloff In This $1 Turnaround Stock Has Created A Buying Opportunity
BioLineRx: Why I See Significant Upside Potential In This $1 Biotech Stock
BioLineRx: At Around $1, This Sleeper Biotech Stock Is A Strong Buy
Stanley Furniture: This $1 Potential Turnaround Stock Is Deeply Undervalued And It Has A 'Hidden Asset'
Jason Industries: This $1 'Turnaround' Stock Is Being Bought By Insiders
One Liberty Properties: Pick Up This 7.6% Yield While It's Cheap
Vaalco Energy: Why This 'Hidden Gem' Is My Favorite Oil Stock For 2017
Vaalco Energy: A Pullback On Earnings Creates A Bargain Buying Opportunity
Vaalco Energy: This $1 Oil Stock Is Deeply Undervalued And Offers Growth Potential
Knoll: This Oversold 'Trump' Stock Is Likely To Rebound Soon
Anthera Pharmaceuticals Now Trading Below Cash Value. This Biotech Could Rise From The Ashes
Histogenics: This $1 Stock Is Trading Below Cash Value And Offers Significant Upside Potential
BioLine Rx: This Under-The-Radar Biotech Stock Is A Strong Buy At $1
AcelRx Pharmaceuticals: Blockbuster Potential Makes This $2 Stock A Strong Buy For 2017
Beaten-Down Biotech And Drugs Stocks Will Outperform In 2017
Catalyst Pharmaceuticals: Why This $1 Biotech Stock Is A Strong Buy For 2017
ImmunoGen: Why This Neglected $1 Biotech Stock Is A Strong Buy Now
Year-End Tax Loss Bargains: 2 'Strategic' Stocks To Buy Now
TransAtlantic Petroleum: Why This $1 Oil Stock Is Now Ripe For Significant Gains
How I Am Investing For $70 Oil In 2017